ACE2 and liver disorder: Several studies have shown that, in the liver, both cholangiocytes and hepatocytes are susceptible to SARS-Cov-2 infection due to their ability to express ACE2, which increases significantly in the presence of pre-existing liver diseases [16,17,18].